» Articles » PMID: 20145124

NOTCH Signaling is Required for Formation and Self-renewal of Tumor-initiating Cells and for Repression of Secretory Cell Differentiation in Colon Cancer

Overview
Journal Cancer Res
Specialty Oncology
Date 2010 Feb 11
PMID 20145124
Citations 148
Authors
Affiliations
Soon will be listed here.
Abstract

NOTCH signaling is critical for specifying the intestinal epithelial cell lineage and for initiating colorectal adenomas and colorectal cancers (CRC). Based on evidence that NOTCH is important for the maintenance and self-renewal of cancer-initiating cells in other malignancies, we studied the role of NOTCH signaling in colon cancer-initiating cells (CCIC). Tumors formed by CCICs maintain many properties of the primary CRCs from which they were derived, such as glandular organization, cell polarity, gap junctions, and expression of characteristic CRC molecular markers. Furthermore, CCICs have the property of self-renewal. In this study, we show that NOTCH signaling is 10- to 30-fold higher in CCIC compared with widely used colon cancer cell lines. Using small-molecule inhibition and short hairpin RNA knockdown, we show that NOTCH prevents CCIC apoptosis through repression of cell cycle kinase inhibitor p27 and transcription factor ATOH1. NOTCH is also critical to intrinsic maintenance of CCIC self-renewal and the repression of secretory cell lineage differentiation genes such as MUC2. Our findings describe a novel human cell system to study NOTCH signaling in CRC tumor initiation and suggest that inhibition of NOTCH signaling may improve CRC chemoprevention and chemotherapy.

Citing Articles

Notch signaling in cancers: mechanism and potential therapy.

Chen C, Du Y, Nie R, Wang S, Wang H, Li P Front Cell Dev Biol. 2025; 13:1542967.

PMID: 40052152 PMC: 11882598. DOI: 10.3389/fcell.2025.1542967.


Molecular Mechanisms of Dietary Compounds in Cancer Stem Cells from Solid Tumors: Insights into Colorectal, Breast, and Prostate Cancer.

Filippi A, Deculescu-Ionita T, Hudita A, Baldasici O, Galateanu B, Mocanu M Int J Mol Sci. 2025; 26(2).

PMID: 39859345 PMC: 11766403. DOI: 10.3390/ijms26020631.


Evaluation of and anticancer activities of potassium koetjapate: a solubility improved formulation of koetjapic acid against human colon cancer.

Jafari S, Keshavarzi M, AbdulMajid A, Al-Suede F, Asif M, Ahamed M Res Pharm Sci. 2024; 19(2):203-216.

PMID: 39035582 PMC: 11257210. DOI: 10.4103/RPS.RPS_247_22.


The SOX2/PDIA6 axis mediates aerobic glycolysis to promote stemness in non-small cell lung cancer cells.

Wan X, Ma D, Song G, Tang L, Jiang X, Tian Y J Bioenerg Biomembr. 2024; 56(3):323-332.

PMID: 38441855 DOI: 10.1007/s10863-024-10009-y.


Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs.

Zhao Q, Zong H, Zhu P, Su C, Tang W, Chen Z Exp Hematol Oncol. 2024; 13(1):6.

PMID: 38254219 PMC: 10802076. DOI: 10.1186/s40164-024-00474-x.


References
1.
Kinzler K, Vogelstein B . Lessons from hereditary colorectal cancer. Cell. 1996; 87(2):159-70. DOI: 10.1016/s0092-8674(00)81333-1. View

2.
Dalerba P, Dylla S, Park I, Liu R, Wang X, Cho R . Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A. 2007; 104(24):10158-63. PMC: 1891215. DOI: 10.1073/pnas.0703478104. View

3.
Zhang H, Ye Y, Bai Z, Wang S . The COX-2 selective inhibitor-independent COX-2 effect on colon carcinoma cells is associated with the Delta1/Notch1 pathway. Dig Dis Sci. 2008; 53(8):2195-203. DOI: 10.1007/s10620-007-0139-0. View

4.
Ricci-Vitiani L, Lombardi D, Pilozzi E, Biffoni M, Todaro M, Peschle C . Identification and expansion of human colon-cancer-initiating cells. Nature. 2006; 445(7123):111-5. DOI: 10.1038/nature05384. View

5.
Akiyoshi T, Nakamura M, Yanai K, Nagai S, Wada J, Koga K . Gamma-secretase inhibitors enhance taxane-induced mitotic arrest and apoptosis in colon cancer cells. Gastroenterology. 2008; 134(1):131-44. DOI: 10.1053/j.gastro.2007.10.008. View